Trial Profile
Women's Health Initiative Memory Study - Epidemiology of Cognitive Health Outcomes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2021
Price :
$35
*
At a glance
- Drugs Conjugated estrogens (Primary) ; Conjugated estrogens/medroxyprogesterone (Primary)
- Indications Alzheimer's disease; Dyspareunia; Menopausal syndrome; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms WHIMS-ECHO
- 22 Nov 2021 Status changed from active, no longer recruiting to completed.
- 07 Mar 2017 Planned End Date changed from 1 May 2016 to 1 Nov 2021.
- 07 Mar 2017 Planned primary completion date changed from 1 May 2016 to 1 Nov 2021.